Subcutaneous mAb May Benefit High-Risk Outpatients With COVID-19
SC casirivimab and imdevimab linked to reduced 28-day hospitalization or death for high-risk outpatients with mild to moderate COVID-19
Overall Risk of Myopericarditis Low After COVID-19 Vaccine
Overall incidence of myopericarditis does not differ significantly for those receiving COVID-19 vaccines versus non-COVID-19 vaccines
Rising COVID-19 Cases in U.S. Not Yet Cause for Alarm: Fauci
There are an average of 31,000 new cases a day nationwide, a 3 percent increase from two weeks ago
Less Than Half of U.S.-Based Clinical Trials Report Race/Ethnicity
Median combined enrollment of minority race/ethnicity groups was below corresponding population demographics based on census estimates
ACC: Infected CV Implantable Electronic Devices Often Not Removed
Although extraction within six days is linked to lower mortality, hardware not removed in 78.9 percent of patients with infected devices
AHA Looks at CV Impact of SARS-CoV-2 Infection in Children
Current knowledge summarized about SARS-CoV-2 infection and associated CV manifestations/complications in children, young adults
~20 Percent of High School Students Report STI Testing
Testing reported by a higher proportion of female than male students; for females, prevalence increased with age
Age, Higher Ferritin Levels Linked to More Severe MIS-C
Children aged 13 to 17 years, 6 to 12 years, with initial ferritin levels >500 µg/L had increased risk for ICU admission
Health Care Employee Turnover Recovering
However, recovery is uneven, particularly among historically marginalized racial and ethnic groups
COVID-19-Associated Acute Myocarditis Reported in 2.4 Per 1,000 Patients
AM occurrence is rare, and outcomes differ based on the presence of COVID-19-associated pneumonia
